VA

VR Adviser Portfolio holdings

AUM $2.02B
1-Year Est. Return 169.23%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+169.23%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.02B
AUM Growth
+$248M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
34
New
Increased
Reduced
Closed

Top Buys

1
+$26.9M
2
+$26.1M
3
+$24.7M
4
MAZE
Maze Therapeutics
MAZE
+$10.9M
5
CBIO
Crescent Biopharma
CBIO
+$9.5M

Top Sells

1
+$196M
2
+$90.7M
3
+$71M
4
COGT icon
Cogent Biosciences
COGT
+$56.2M
5
ABVX
Abivax
ABVX
+$49M

Sector Composition

1 Healthcare 100%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARTV
26
Artiva Biotherapeutics
ARTV
$141M
$6.91M 0.34%
1,609,569
CASI
27
DELISTED
CASI Pharmaceuticals
CASI
$839K 0.04%
987,259
ABVX
28
Abivax
ABVX
$8.65B
– –
-576,729
ATXS
29
DELISTED
Astria Therapeutics
ATXS
– –
-2,457,348
CDTX
30
DELISTED
Cidara Therapeutics
CDTX
– –
-946,788
PHVS icon
31
Pharvaris
PHVS
$1.68B
– –
-674,599
TENX icon
32
Tenax Therapeutics
TENX
$66.7M
– –
-437,708
PCSC
33
Perceptive Capital Solutions
PCSC
$127M
– –
-750,000
MTSR
34
DELISTED
Metsera Inc
MTSR
– –
-3,750,662
1
2